[1] |
DU Shuxiang, ZHAO Yingzhi, ZHANG Xuetao, WANG Tao, LUO Jingyu, ZHANG Wei, WU Gang.
Analysis of group 12a lymph node metastasis at different sites of gastric adenocarcinoma and its risk factors
[J]. China Oncology, 2023, 33(6): 597-604.
|
[2] |
YUAN Xinyue, YAO Yao, CHENG Shuai, ZHENG Xin, ZHANG Yuan.
Clinical study on high-risk factors for contralateral lymph node metastasis in unilateral papillary thyroid carcinoma
[J]. China Oncology, 2023, 33(6): 619-628.
|
[3] |
ZHENG Xiuli, YAO Zhiyuan, WU Mingli, ER Limian, LI Shengmian.
Analysis of risk factors of lymph node metastasis and comparison of endoscopic resection methods in rectal neuroendocrine neoplasm
[J]. China Oncology, 2022, 32(9): 800-806.
|
[4] |
MEI Xiaoran, FENG Fang, WANG Hui, WEI Zhixiao.
Analysis of therapeutic response of iodine positive metastasis lymph nodes in differentiated thyroid cancer after 131I treatment
[J]. China Oncology, 2022, 32(11): 1091-1097.
|
[5] |
JIANG Chaoyang , WANG Juan , ZHANG Ling , GAO Hui , ZHANG Tao , LI Zhihui .
Correlation analysis of neck node levels in 709 cases of nasopharyngeal carcinoma
[J]. China Oncology, 2021, 31(7): 629-634.
|
[6] |
YU Lei , DAI Zhi , WANG Zheng , ZHANG Yong , CHEN Qing .
The impact of lymph node metastasis on the clinical parameters and prognosis of intrahepatic cholangiocarcinoma patients after curative resection
[J]. China Oncology, 2020, 30(9): 694-700.
|
[7] |
MU Zhuanzhuan , LI Zheng , ZHANG Xin , LIN Yansong .
The effect of empiric 131 I therapy in papillary thyroid cancer patients with pulmonary metastasis
[J]. China Oncology, 2020, 30(12): 991-995.
|
[8] |
REN Junling , CHEN Bin , TANG Xiaolei .
Research on the correlation between BMI and pathologic factors of papillary thyroid carcinoma
[J]. China Oncology, 2020, 30(12): 1041-1045.
|
[9] |
LI Menglei , ZHANG Jing , DAN Yibo , YANG Guang , YAO Yefeng , TONG Tong .
Development and validation of a clinical-radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer
[J]. China Oncology, 2020, 30(1): 49-56.
|
[10] |
MA Xiaokai,HUANG Jiankang,ZHU Bo,PENG Defeng,ZHOU Rui,WANG Shengying .
Clinical characteristics of papillary thyroid microcarcinoma and risk factors for cervical lymph node metastasis: a clinical analysis of 228 cases
[J]. China Oncology, 2019, 29(8): 590-594.
|
[11] |
LU Chenghui, LI Jiao, LIU Xinfeng, WANG Guoqiang, WANG Zenghua, WANG Xufu.
Clinical outcome after 131I treatment in differentiated thyroid cancer with negative stimulated thyroglobulin and lymph node metastasis
[J]. China Oncology, 2019, 29(6): 429-433.
|
[12] |
LIU Mengjun, LI Yuzhi, WANG Lihua, CHANG Mengran.
Clinical significance of squamous cell carcinoma antigen combined with magnetic resonance imaging in diagnosing pelvic lymph node metastasis of early cervical cancer
[J]. China Oncology, 2019, 29(2): 136-141.
|
[13] |
SHEN Haoyuan, HU Chaohua, HAN Yuntao, et al.
The exploration of clinical pathological characteristics and the diagnosis and treatment strategy of 56 patients with occult breast cancer
[J]. China Oncology, 2018, 28(6): 429-434.
|
[14] |
WANG Fen, CHANG Cai.
Diagnostic value of ultrasound-guided fine needle aspiration in assessment of cervical lymph node in head and neck carcinoma
[J]. China Oncology, 2017, 27(6): 421-424.
|
[15] |
ZHAO Teng, GAO Wen, LIANG Jun, et al.
The relationship between the number of dissected central lymph nodes and clinical outcome in pN1a papillary thyroid carcinoma
[J]. China Oncology, 2017, 27(4): 256-261.
|